Analysis of Ultra Low Genome Conservation in Clostridium difficile

Microarray-based comparative genome hybridisations (CGH) and genome sequencing of Clostridium difficile isolates have shown that the genomes of this species are highly variable. To further characterize their genome variation, we employed integration of data from CGH, genome sequencing and putative cellular pathways. Transcontinental strain comparison using CGH data confirmed the emergence of a human-specific hypervirulent cluster. However, there was no correlation between total toxin production and hypervirulent phenotype, indicating the possibility of involvement of additional factors towards hypervirulence. Calculation of C. difficile core and pan genome size using CGH and sequence data estimated that the core genome is composed of 947 to 1,033 genes and a pan genome comprised of 9,640 genes. The reconstruction, annotation and analysis of cellular pathways revealed highly conserved pathways despite large genome variation. However, few pathways such as tetrahydrofolate biosynthesis were found to be variable and could be contributing to adaptation towards virulence such as antibiotic resistance.

[1]  Joy Scaria,et al.  Transcriptional profiling of Clostridium difficile and Caco-2 cells during infection. , 2010, The Journal of infectious diseases.

[2]  Andries J. van Tonder,et al.  Evolutionary dynamics of Clostridium difficile over short and long time scales , 2010, Proceedings of the National Academy of Sciences.

[3]  M. Quail,et al.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium , 2009, Genome Biology.

[4]  Xilin Zhao,et al.  Quinolones: Action and Resistance Updated , 2009, Current topics in medicinal chemistry.

[5]  S. Clare,et al.  Proteomic and Genomic Characterization of Highly Infectious Clostridium difficile 630 Spores , 2009, Journal of bacteriology.

[6]  Malcolm J. McConville,et al.  LeishCyc: a biochemical pathways database for Leishmania major , 2009, BMC Systems Biology.

[7]  E. Kuijper,et al.  Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  Joy Scaria,et al.  Microarray Identification of Clostridium difficile Core Components and Divergent Regions Associated with Host Origin , 2009, Journal of bacteriology.

[9]  S. Bentley,et al.  Sequencing the species pan-genome , 2009, Nature Reviews Microbiology.

[10]  Joel Dudley,et al.  MEGA: A biologist-centric software for evolutionary analysis of DNA and protein sequences , 2008, Briefings Bioinform..

[11]  N. Fairweather,et al.  Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress. , 2008, Journal of medical microbiology.

[12]  M. Delmée,et al.  Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. , 2008, Journal of medical microbiology.

[13]  M. Unemo,et al.  Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1 , 2008, Journal of Clinical Microbiology.

[14]  E. Kuijper,et al.  First isolation of Clostridium difficile PCR-ribotype 027/toxinotype III in Poland. , 2008, Polish journal of microbiology.

[15]  Balázs Papp,et al.  Metabolic reconstruction and analysis for parasite genomes. , 2007, Trends in Parasitology.

[16]  Evan Powell,et al.  Comparative Genomic Analyses of Seventeen Streptococcus pneumoniae Strains: Insights into the Pneumococcal Supragenome , 2007, Journal of bacteriology.

[17]  S. Weese,et al.  Prevalence of PCR Ribotypes among Clostridium difficile Isolates from Pigs, Calves, and Other Species , 2007, Journal of Clinical Microbiology.

[18]  M. Dionne,et al.  A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  A. Witney,et al.  Comparative Phylogenomics of Clostridium difficile Reveals Clade Specificity and Microevolution of Hypervirulent Strains , 2006, Journal of bacteriology.

[20]  Suzanne M. Paley,et al.  The Pathway Tools cellular overview diagram and Omics Viewer , 2006, Nucleic acids research.

[21]  Julian Parkhill,et al.  The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome , 2006, Nature Genetics.

[22]  P. Karp,et al.  Evidence supporting predicted metabolic pathways for Vibrio cholerae: gene expression data and clinical tests , 2006, Nucleic acids research.

[23]  T. Åkerlund,et al.  Correlation of Disease Severity with Fecal Toxin Levels in Patients with Clostridium difficile-Associated Diarrhea and Distribution of PCR Ribotypes and Toxin Yields In Vitro of Corresponding Isolates , 2006, Journal of Clinical Microbiology.

[24]  J. Songer,et al.  Clostridium difficile: an important pathogen of food animals. , 2006, Anaerobe.

[25]  W. Liang,et al.  TM4 microarray software suite. , 2006, Methods in enzymology.

[26]  A. Ryan,et al.  Sequence and phylogenetic analysis of the gene for surface layer protein, slpA, from 14 PCR ribotypes of Clostridium difficile. , 2006, Journal of medical microbiology.

[27]  W. Liang,et al.  9) TM4 Microarray Software Suite , 2006 .

[28]  Stuart Johnson,et al.  An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.

[29]  Jason Hinds,et al.  Comparative phylogenomics of the food-borne pathogen Campylobacter jejuni reveals genetic markers predictive of infection source. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Francke,et al.  Reconstructing the metabolic network of a bacterium from its genome. , 2005, Trends in microbiology.

[31]  J. Lemeland,et al.  Multilocus sequence analysis and comparative evolution of virulence-associated genes and housekeeping genes of Clostridium difficile. , 2005, Microbiology.

[32]  Christian Kraft,et al.  Gain and Loss of Multiple Genes During the Evolution of Helicobacter pylori , 2005, PLoS genetics.

[33]  Jaideep P. Sundaram,et al.  Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Jon Brazier,et al.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe , 2005, The Lancet.

[35]  James R. Knight,et al.  Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.

[36]  N. Fairweather,et al.  Proteomic analysis of cell surface proteins from Clostridium difficile , 2005, Proteomics.

[37]  Floyd E Romesberg,et al.  Inhibition of Mutation and Combating the Evolution of Antibiotic Resistance , 2005, PLoS biology.

[38]  J. Weese,et al.  PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. , 2005, Journal of medical microbiology.

[39]  Louis Valiquette,et al.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity , 2004, Canadian Medical Association Journal.

[40]  Peter D. Karp,et al.  A Bayesian method for identifying missing enzymes in predicted metabolic pathway databases , 2004, BMC Bioinformatics.

[41]  C. Stoeckert,et al.  OrthoMCL: identification of ortholog groups for eukaryotic genomes. , 2003, Genome research.

[42]  Stanley Falkow,et al.  Improved analytical methods for microarray-based genome-composition analysis , 2002, Genome Biology.

[43]  J. Derrick,et al.  The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[44]  M. Delmée,et al.  Clostridium difficile Genotyping Based on slpA Variable Region in S-Layer Gene Sequence: an Alternative to Serotyping , 2002, Journal of Clinical Microbiology.

[45]  Peter D. Karp,et al.  The Pathway Tools software , 2002, ISMB.

[46]  Peter D. Karp,et al.  Evaluation of computational metabolic-pathway predictions for Helicobacter pylori , 2002, Bioinform..

[47]  D. Pardi,et al.  Clostridium difficile-associated diarrhea and colitis. , 2001, Mayo Clinic proceedings.

[48]  D. Gerding,et al.  Clostridium difficile--associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  J. Domagala,et al.  DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  F. M. Huennekens,et al.  Membrane-associated folate transport proteins. , 1986, Methods in enzymology.